CSIMarket
 


Novan Inc   (NOVN)
Other Ticker:  
 
 

NOVN's Revenue Growth by Quarter and Year

Novan Inc 's Revenue results by quarter and year




NOVN Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - 1.38 4.04 0.62
III Quarter September - 1.32 0.65 0.75
II Quarter June - 1.10 0.65 0.67
I Quarter March 1.21 1.10 0.66 0.10
FY   1.21 4.90 6.00 2.14



NOVN Revenue first quarter 2020 Y/Y Growth Comment
Novan Inc reported Revenue increase of 10.27% year on year in the first quarter, to $ 1.21 millions, this is lower than Novan Inc 's recent average Revenue surge of 141.74%.

Looking into first quarter results within Major Pharmaceutical Preparations industry 77 other companies have achieved higher Revenue growth. While Novan Inc ' s Revenue growth of 10.27% ranks overall at the positon no. 974 in the first quarter.




NOVN Revenue ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - -65.84 % 551.61 % -
III Quarter September - 103.08 % -13.33 % -
II Quarter June - 69.23 % -2.99 % -
I Quarter March 10.27 % 66.67 % 560 % -
FY   - -18.33 % 180.37 % -

Financial Statements
Novan Inc 's first quarter 2020 Revenue $ 1.21 millions NOVN's Income Statement
Novan Inc 's first quarter 2019 Revenue $ 1.10 millions Quarterly NOVN's Income Statement
New: More NOVN's historic Revenue Growth >>


NOVN Revenue (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - 4.55 % 521.54 % -17.33 %
III Quarter September - 20 % 0 % 11.94 %
II Quarter June - 0 % -1.52 % 570 %
I Quarter March -12.1 % -72.77 % 6.45 % -
FY (Year on Year)   - -18.33 % 180.37 % -




Revenue first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #78
Healthcare Sector #212
Overall #974

Revenue Y/Y Growth Statistics
High Average Low
558 % 141.74 % -65.83 %
(Mar 31 2018)   (Dec 31 2019)
Revenue first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #78
Healthcare Sector #212
Overall #974
Revenue Y/Y Growth Statistics
High Average Low
558 % 141.74 % -65.83 %
(Mar 31 2018)   (Dec 31 2019)

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Novan Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
569 % 85.9 % -72.75 %
(Jun 30 2017)  


NOVN's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2020 Novan Inc realized drop in Revenue from the previous quarter by -12.1% to $ 1.21 millions, from $ 1.38 millions achived in the previous reporting period.

When you look into present slump at the I. Quarter, you should presume, that frequently I. Quarter performance occur softer relative to the quarter before

Within Major Pharmaceutical Preparations industry 94 other companies have achieved higher Revenue quarter on quarter growth. While Novan Inc 's Revenue growth quarter on quarter, overall rank is 1976.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #95
Healthcare Sector #275
Overall #1976
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #95
Healthcare Sector #275
Overall #1976
Revenue Q/Q Growth Statistics
High Average Low
569 % 85.9 % -72.75 %
(Jun 30 2017)  


NOVN's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2020 Novan Inc reported drop in Revenue from the previous quarter by -12.1% to $ 1.21 millions, from $ 1.38 millions released in the previous qaurter.

As we analyse current slump in the quarter, we must presume, that frequently I. Quarter performance emerge sluggish in contrast to the preciding period, Faith  Roberts, a business expert mentioned.

Within Major Pharmaceutical Preparations industry 94 other companies have achieved higher Revenue quarter on quarter growth. While Novan Inc 's Revenue growth quarter on quarter, overall rank is 1976.


Novan Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative Revenue 12 Months Ending $ 5.01 $ 4.90 $ 7.55 $ 6.89 $ 6.43
Y / Y Revenue Growth (TTM) -22.14 % -18.28 % 193.21 % 157.09 % 138.44 %
Year on Year Revenue Growth Overall Ranking # 2620 # 1021 # 93 # 127 # 138
Seqeuential Revenue Change (TTM) 2.31 % -35.18 % 9.7 % 7.03 % 7.38 %
Seq. Revenue Growth (TTM) Overall Ranking # 896 # 1131 # 434 # 628 # 412




Cumulative Revenue growth Comment
Novan Inc 's cumulative 12 months Revenue continue to fall, but on the faster rate at -22.14% year on year, at Mar 31 2020 compare to the -18.28% decrease at Dec 31 2019. If the Novan Inc 's fiscal year would end at Mar 31 2020, annual Revenue would be $5 millions.

In the Healthcare sector 338 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1021 to 2620.

Revenue TTM Q/Q Growth Statistics
High Average Low
132.57 %
20.63 %
-35.18 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 75
Healthcare Sector # 339
Overall # 2620

Revenue TTM Y/Y Growth Statistics
High Average Low
193.21 %
104.71 %
-22.14 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 75
Sector # 201
S&P 500 # 896
Cumulative Revenue growth Comment
Novan Inc 's cumulative 12 months Revenue continue to fall, but on the faster rate at -22.14% year on year, at Mar 31 2020 compare to the -18.28% decrease at Dec 31 2019. If the Novan Inc 's fiscal year would end at Mar 31 2020, annual Revenue would be $5 millions.

In the Healthcare sector 338 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1021 to 2620.

Revenue TTM Q/Q Growth Statistics
High Average Low
132.57 %
20.63 %
-35.18 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 75
Healthcare Sector # 339
Overall # 2620

Revenue TTM Y/Y Growth Statistics
High Average Low
193.21 %
104.71 %
-22.14 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 75
Sector # 201
S&P 500 # 896




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NOVN's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NOVN's Competitors
Revenue Growth for Novan Inc 's Suppliers
Revenue Growth for NOVN's Customers

You may also want to know
NOVN's Annual Growth Rates NOVN's Profitability Ratios NOVN's Asset Turnover Ratio NOVN's Dividend Growth
NOVN's Roe NOVN's Valuation Ratios NOVN's Financial Strength Ratios NOVN's Dividend Payout Ratio
NOVN's Roa NOVN's Inventory Turnover Ratio NOVN's Growth Rates NOVN's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2020
Kindred Biosciences Inc   17.09 %$ 17.087 millions
Charles River Laboratories International inc   16.95 %$ 16.953 millions
Ironwood Pharmaceuticals inc   16.31 %$ 16.315 millions
Resmed Inc   16.19 %$ 16.192 millions
Tactile Systems Technology Inc   16.10 %$ 16.104 millions
Pacira Biosciences inc   15.74 %$ 15.738 millions
Luna Innovations Inc  15.56 %$ 15.559 millions
Predictive Oncology Inc   15.55 %$ 15.555 millions
Vbi Vaccines Inc  15.28 %$ 15.278 millions
Eli Lilly And Company  15.07 %$ 15.074 millions
Petmed Express Inc  15.06 %$ 15.056 millions
Medpace Holdings inc   15.01 %$ 15.013 millions
Navidea Biopharmaceuticals Inc   14.88 %$ 14.879 millions
Sangui Biotech International Inc  14.25 %$ 14.252 millions
Meridian Bioscience Inc  14.03 %$ 14.026 millions
Endo International Plc  13.88 %$ 13.880 millions
Edwards Lifesciences Corporation  13.67 %$ 13.666 millions
Intuitive Surgical Inc   12.92 %$ 12.920 millions
Alimera Sciences Inc  12.76 %$ 12.762 millions
Seres Therapeutics Inc   11.86 %$ 11.856 millions
Chemed Corporation  11.64 %$ 11.636 millions
Orthopediatrics Corp  11.60 %$ 11.599 millions
Merck and Co Inc   11.47 %$ 11.474 millions
Immucell Corp  11.33 %$ 11.333 millions
Vaso Corp  11.33 %$ 11.331 millions
Supernus Pharmaceuticals inc   11.12 %$ 11.117 millions
West Pharmaceutical Services Inc   10.82 %$ 10.823 millions
Alkermes Plc   10.36 %$ 10.362 millions
Novan Inc   10.27 %$ 10.273 millions
Abbvie Inc   10.10 %$ 10.105 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

UAMY's Profile

Stock Price

UAMY's Financials

Business Description

Fundamentals

Charts & Quotes

UAMY's News

Suppliers

UAMY's Competitors

Customers & Markets

Economic Indicators

UAMY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071